Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Owens

Showing results (11-20 of 707) with videos related to

Pageof 71
Sort By:
American Annals of the Deaf|November 1, 1987
Issues facing people with hearing impairments and the 100th CongressM R Owens
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2016
Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevanceDavid R Owens
European Journal of Clinical Investigation|June 26, 1999
Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetesD R Owens
Business and Health|April 8, 1993
How insurers can regain buyers' confidenceT R Owens
Revolution (Staten Island, N.Y.)|January 1, 1996
A word from WashingtonM R Owens
EMBO Reports|December 18, 2001
Being prepared. Preparations for a pandemic of influenzaS R Owens
Expert Review of Endocrinology & Metabolism|February 14, 2019
Optimizing treatment strategies with insulin glargine in Type 2 diabetesDavid R Owens
EMBO Reports|May 7, 2002
Injection of confidence. The recent controversy in the UK has led to falling MMR vaccination ratesSusan R Owens
Dental Economics - Oral Hygiene|September 1, 1992
It could happen to youS R Owens
EMBO Reports|March 14, 2003
Feeding prejudice. Reluctance within the European Union to accept genetically modified crops may hinder the benefits of this technology reaching the developing worldSusan R Owens
Pageof 71

Showing results (11-20 of 707) with videos related to

Sort By:
Pageof 71
American Annals of the Deaf|November 1, 1987
Issues facing people with hearing impairments and the 100th CongressM R Owens
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2016
Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevanceDavid R Owens
European Journal of Clinical Investigation|June 26, 1999
Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetesD R Owens
Business and Health|April 8, 1993
How insurers can regain buyers' confidenceT R Owens
Revolution (Staten Island, N.Y.)|January 1, 1996
A word from WashingtonM R Owens
EMBO Reports|December 18, 2001
Being prepared. Preparations for a pandemic of influenzaS R Owens
Expert Review of Endocrinology & Metabolism|February 14, 2019
Optimizing treatment strategies with insulin glargine in Type 2 diabetesDavid R Owens
EMBO Reports|May 7, 2002
Injection of confidence. The recent controversy in the UK has led to falling MMR vaccination ratesSusan R Owens
Dental Economics - Oral Hygiene|September 1, 1992
It could happen to youS R Owens
EMBO Reports|March 14, 2003
Feeding prejudice. Reluctance within the European Union to accept genetically modified crops may hinder the benefits of this technology reaching the developing worldSusan R Owens
Pageof 71